EHRA Premium Access

Acute safety and efficacy outcome of pulmonary vein isolation using pulsed field ablation technology

Presentation

About the speaker

Doctor Karin Nentwich

Rhoen clinic AG, Bad Neustadt a. d. Saale (Germany)
1 presentation
0 follower

5 more presentations in this session

Optimizing catheter ablation of atrial fibrillation by a novel wide-band dielectric imaging system: first experience on real-time wall thickness measurement

Speaker: Doctor L. Rottner (Hamburg, DE)

Thumbnail

Periaortic scar-related ventricular tachycardia in patients with aortic valve replacement: transcatheter ablation is feasible and decisive.

Speaker: Doctor L. Cardelli (Bologna, IT)

Thumbnail

Zero-fluoroscopy catheter ablation in pregnant women: outcomes and prognosis

Speaker: Doctor A. Smagulova (Nursultan, KZ)

Thumbnail

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

Speaker: Doctor C. Martin (Cambridge, GB)

Thumbnail

Influence of atrial cycle length and site of origin on the peak frequency of bipolar electrograms to discriminate isthmus conduction in atrial scar

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Access the full session

Moderated ePosters - Tips and trics to optimize ablation

Speakers: Doctor K. Nentwich, Doctor L. Rottner, Doctor L. Cardelli, Doctor A. Smagulova, Doctor C. Martin...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

Biventricular versus conduction system pacing after atrioventricular node ablation in heart failure patients with atrial fibrillation

3 April 2022

This platform is supported by

logo Novo Nordisk